Researcher at University of British Columbia Reports Research in Cannabigerol (Combinations of Cannabinoids with Silver Salts or Silver Nanoparticles for Synergistic Antibiotic Effects against Methicillin-Resistant Staphylococcus aureus).

A recent study conducted at the University of British Columbia explored the antibiotic potential of various cannabinoids, including cannabidiol (CBD), cannabichromene (CBC), and cannabigerol (CBG), against methicillin-resistant Staphylococcus aureus (MRSA). The researchers found that all six cannabinoids exhibited strong antibiotic effects against MRSA, with CBG, CBD, and CBCA having the lowest minimal inhibitory concentrations (MICs). Additionally, the study investigated the synergistic effects of silver nitrate and silver nanoparticles with the cannabinoids, finding that combinations of CBC, CBGA, and CBG with silver nitrate or silver nanoparticles demonstrated strong inhibition of bacterial growth and bactericidal effects. These findings suggest potential biomedical applications for specific cannabinoids in combination with silver salts or nanoparticles against drug-resistant Gram-positive bacteria. [Extracted from the article]